FDA Authority To Force Antihistamine Switch Denounced By Pfizer Chief
FDA lacks the statutory power to force a prescription antihistamine to switch OTC, Pfizer CEO Henry McKinnell insisted during an analysts call April 18.
FDA lacks the statutory power to force a prescription antihistamine to switch OTC, Pfizer CEO Henry McKinnell insisted during an analysts call April 18.